Japan Preclinical CRO Market Report by Service (Bioanalysis and DMPK Studies, Toxicology Testing, and Others), End Use (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), and Region 2025-2033
일본의 전임상 CRO 시장의 시장 규모는 2024년에 2억 4,320만 달러에 달했습니다. IMARC Group은 2025-2033년 성장률(CAGR)이 8.3%로, 2033년에는 5억 3,990만 달러에 달할 것으로 예측하고 있습니다. 이 시장은 각사가 자사의 핵심이 되는 강점을 중시하고, 특수 치료에서 최근 획기적인 진보를 배경으로 큰 기세를 보이고 있습니다.
본 리포트에서 답변하는 주요 질문
- 일본의 전임상 CRO 시장은 지금까지 어떻게 추이하며, 향후 어떻게 추이하는가?
- 일본의 전임상 CRO 시장에 대한 COVID-19의 영향은?
- 일본의 전임상 CRO 시장의 서비스별 내역은?
- 일본의 전임상 CRO 시장의 최종 용도별 내역은?
- 일본의 전임상 CRO 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본의 전임상 CRO에서 주요 촉진요인과 과제는 무엇인가?
- 일본의 전임상 CRO 시장의 구조와 주요 기업은?
- 일본의 전임상 CRO 시장에서 경쟁의 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 일본의 전임상 CRO 시장 : 서론
제5장 일본의 전임상 CRO 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033)
제6장 일본의 전임상 CRO 시장 : 서비스별 내역
제7장 일본의 전임상 CRO 시장 : 최종 용도별 내역
- 바이오의약품 기업
- 정부기관 및 학술기관
- 의료기기 기업
제8장 일본의 전임상 CRO 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제9장 주요 기업의 개요
제10장 일본의 전임상 CRO 시장 : 업계 분석
- 촉진요인·억제요인·기회
- Porter's Five Forces 분석
- 밸류체인 분석
제11장 부록
KSA
Japan preclinical CRO market size reached USD 243.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 539.9 Million by 2033, exhibiting a growth rate (CAGR) of 8.3% during 2025-2033. The market is witnessing significant momentum due to a heightened emphasis among companies on their core strengths and recent breakthroughs in specialized treatments.
A preclinical contract research organization (CRO) is a company that delivers diverse research and development (R&D) services to the biotechnology, pharmaceutical, and medical device sectors. These services encompass a wide spectrum, including toxicology investigations, pharmacokinetic assessments, formulation development, regulatory assistance, and pharmacodynamic studies. The applications of preclinical CRO services span various domains, encompassing drug discovery, medical device evaluation, biocompatibility assessments, disease modeling, safety pharmacology investigations, and the selection of appropriate dosage forms. These services facilitate the acceleration of product development, bolster compliance with regulatory requirements, tap into specialized expertise, optimize resource allocation, and offer flexible research solutions.
Japan Preclinical CRO Market Trends:
In the context of the Japanese market, there is an increasing emphasis among companies on concentrating their efforts on their core competencies. This trend is driving the demand for preclinical contract research organizations (CROs) as they enable companies to delegate specialized preclinical tasks, allowing them to allocate more resources to their primary areas of focus, such as late-phase clinical trials or marketing endeavors. Moreover, the surging demand for preclinical CRO services in Japan is linked to the rapid expansion of the pharmaceutical sector in emerging economies, driven by the need to address unique healthcare challenges and cater to a growing patient population. Additionally, the market is benefiting from recent advancements in specialized treatments like personalized medicine, biologics, and gene therapies, which necessitate precise and nuanced preclinical testing. Furthermore, the widespread adoption of preclinical CROs is driven by the desire to adopt a risk-balanced approach, especially in light of the high failure rate in drug development. Lastly, the introduction of cutting-edge technologies that play a pivotal role in the successful execution of preclinical studies is expected to bolster the market's growth prospects in Japan over the forecasted period.
Japan Preclinical CRO Market Segmentation:
Service Insights:
- Bioanalysis and DMPK Studies
- Toxicology Testing
- Others
End Use Insights:
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan preclinical CRO market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan preclinical CRO market?
- What is the breakup of the Japan preclinical CRO market on the basis of service?
- What is the breakup of the Japan preclinical CRO market on the basis of end use?
- What are the various stages in the value chain of the Japan preclinical CRO market?
- What are the key driving factors and challenges in the Japan preclinical CRO?
- What is the structure of the Japan preclinical CRO market and who are the key players?
- What is the degree of competition in the Japan preclinical CRO market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Preclinical CRO Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Preclinical CRO Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Preclinical CRO Market - Breakup by Service
- 6.1 Bioanalysis and DMPK Studies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Toxicology Testing
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Others
- 6.3.1 Historical and Current Market Trends (2019-2024)
- 6.3.2 Market Forecast (2025-2033)
7 Japan Preclinical CRO Market - Breakup by End Use
- 7.1 Biopharmaceutical Companies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Government and Academic Institutes
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Medical Device Companies
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
8 Japan Preclinical CRO Market - Competitive Landscape
- 8.1 Overview
- 8.2 Market Structure
- 8.3 Market Player Positioning
- 8.4 Top Winning Strategies
- 8.5 Competitive Dashboard
- 8.6 Company Evaluation Quadrant
9 Profiles of Key Players
- 9.1 Company A
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
- 9.2 Company B
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
- 9.3 Company C
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
- 9.4 Company D
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
- 9.5 Company E
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events
10 Japan Preclinical CRO Market - Industry Analysis
- 10.1 Drivers, Restraints, and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
- 10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
- 10.3 Value Chain Analysis
11 Appendix
